Carotid stenosis after TIA or stroke

01OverviewDefinition, clinical context and the essential points that orientate the chapter.

Symptomatic carotid stenosis means that an ipsilateral retinal or cerebral ischaemic event can reasonably be attributed to an extracranial internal carotid atherosclerotic lesion. Typical events include amaurosis fugax, hemispheric TIA and non-disabling ischaemic stroke. A coincidental bruit or stenosis on the opposite side does not establish causality. The clinician must connect symptom territory, timing and vascular anatomy while still investigating cardiac and intracranial alternatives.

Risk of recurrent stroke is front-loaded after a TIA or minor stroke, which makes urgent assessment and early prevention important. In neurologically stable people with 50–99% stenosis by NASCET criteria, CEA can remove an embolic plaque and reduce later ipsilateral stroke. Benefit rises with stenosis severity but is modified by time since symptoms, disability, infarct size, anatomy, comorbidity and the local procedural stroke/death risk. Near-occlusion and complete occlusion need specialist interpretation rather than simple application of a percentage threshold.

Carotid prevention is distinct from hyperacute stroke treatment. A patient with current deficit first needs acute stroke imaging and reperfusion assessment. Once stable, carotid imaging and the endarterectomy pathway run quickly alongside antiplatelet treatment, lipid lowering and risk-factor control. Major infarction or haemorrhage can make very early surgery hazardous because restored pressure may precipitate haemorrhagic transformation.

Key points

Treat new focal neurological symptoms as stroke first: use the emergency pathway, exclude haemorrhage and assess reperfusion eligibility before carotid prevention.
Suspected TIA needs immediate aspirin 300 mg daily unless contraindicated and immediate specialist referral for assessment within 24 hours; do not use ABCD2 to delay referral.
Stable non-disabling stroke or TIA with ipsilateral 50–99% NASCET symptomatic stenosis needs urgent vascular referral, best medical treatment and consideration of CEA, ideally within 14 days when suitable.
A symptomatic stenosis below 50% NASCET should not undergo endarterectomy; continue best medical treatment and seek other stroke mechanisms.
Duplex is first-line carotid imaging, but the report must state NASCET or ECST convention and uncertain treatment-determining anatomy needs confirmation.
Major disabling stroke, large infarction, intracranial haemorrhage, impaired consciousness or unstable neurology requires multidisciplinary reassessment before early CEA.
Carotid plaque does not itself justify anticoagulation; identify atrial fibrillation or another cardioembolic indication separately.
Continue long-term vascular prevention after the acute episode, including antithrombotic therapy, high-intensity lipid lowering, blood-pressure control and smoking support.

02AetiologyUnderlying causes, associations and risk factors, with why each one matters.

Atherosclerotic plaque

Lipid-rich and fibrotic plaque develops most often at the carotid bifurcation under the influence of smoking, hypertension, diabetes, dyslipidaemia, age and systemic atherosclerotic susceptibility.

Competing embolic sources

Atrial fibrillation, aortic plaque and intracranial arterial disease can coexist with carotid stenosis, so anatomical association must be tested against clinical territory and timing.

03PathophysiologyThe causal sequence from the underlying abnormality to symptoms and harm.

1
Artery-to-artery embolism
Plaque rupture, surface thrombus or friable material releases emboli into ipsilateral retinal or cerebral arteries, producing transient ischaemia or infarction even without critical flow limitation.
2
Haemodynamic compromise
Severe stenosis or near-occlusion can reduce distal perfusion, particularly when collateral supply is poor, making symptoms vulnerable to hypotension and impaired cerebrovascular reserve.
3
Front-loaded recurrence
An active symptomatic plaque carries its greatest recurrent embolic risk soon after the presenting event, while successful plaque removal offers less absolute benefit as treatment is delayed.

04Clinical features and red flagsSymptoms, examination findings, patterns of presentation and time-critical warnings.

Retinal ischaemia

Transient monocular visual loss or retinal artery occlusion can localise to the ipsilateral carotid circulation and counts as symptomatic disease.

Hemispheric TIA

Contralateral face or limb weakness, sensory loss, dysphasia or neglect resolving completely suggests an anterior-circulation embolic event.

Non-disabling stroke

A recent infarct with stable useful function may still allow early CEA after brain imaging and multidisciplinary assessment.

Active stroke deficitRed flag

Persistent or evolving focal neurological loss requires hyperacute stroke assessment before any preventive carotid decision.

High-risk brain injuryRed flag

Large territorial infarction, haemorrhage, impaired consciousness or major disability raises perioperative haemorrhage risk and can justify deferral.

Incidental disease

A bruit or stenosis without a relevant ipsilateral event is asymptomatic disease and follows a different risk-benefit pathway.

Red flags requiring action

Ongoing weakness, aphasia, neglect, visual loss or reduced consciousness requires immediate acute stroke assessment.
A fluctuating or repeatedly recurring deficit may represent unstable cerebral perfusion or continuing embolisation and needs urgent specialist review.
A large infarct, haemorrhagic transformation, major disabling deficit or impaired consciousness changes the safety and timing of carotid intervention.

05InvestigationsWhat to request, why it matters and how to interpret it.

Investigation order

Read from the initial assessment onwards. Tests may run in parallel in urgent care; first-line, preferred, confirmatory, definitive and gold-standard labels appear only when the chapter explicitly states them.

01
Urgent brain imagingFirst step
Why
Exclude haemorrhage, assess infarct burden and support reperfusion decisions
Interpretation and limitations
CT or MRI findings define the acute stroke pathway; a large infarct or haemorrhagic change also alters CEA timing.
02
Carotid duplex ultrasound
Why
Identify and grade extracranial carotid plaque and stenosis
Interpretation and limitations
Use validated velocity and waveform criteria with a NASCET-equivalent grade; calcification, low flow and tandem disease can reduce accuracy.
03
CTA or contrast-enhanced MRA
Why
Confirm treatment-determining stenosis and map vascular anatomy
Interpretation and limitations
Cross-sectional angiography clarifies lumen, arch and intracranial circulation, but contrast, renal, radiation and device limitations guide modality choice.
04
ECG and rhythm monitoring
Why
Detect atrial fibrillation or another cardiac embolic mechanism
Interpretation and limitations
A cardioembolic source can change long-term antithrombotic treatment and may show that a carotid lesion is incidental rather than causal.
05
Baseline vascular blood tests
Why
Assess bleeding risk, renal function, diabetes and lipids
Interpretation and limitations
Full blood count, renal and liver function, glucose or HbA1c and lipids guide medication safety and secondary-prevention targets.

06Differential diagnosisRealistic alternatives and the features that help distinguish them.

Cardioembolic stroke

Atrial fibrillation, ventricular thrombus or valvular disease can produce cortical or retinal embolism and changes long-term antithrombotic management if it better explains the event.

Intracranial arterial disease

Intracranial stenosis or occlusion can cause the same hemispheric territory, requiring intracranial vascular imaging and a different intervention strategy from extracranial CEA.

Stroke mimics

Migraine aura, focal seizure, hypoglycaemia and functional neurological symptoms may resemble TIA; positive spreading symptoms or metabolic findings require careful specialist interpretation.

07ManagementImmediate care, first-line treatment, alternatives and escalation.

01ManagementRecent stable TIA or minor strokeFirst stepIpsilateral retinal or cerebral symptoms have resolved or stabilised without major disability

1Refer immediately to a stroke specialist pathway; suspected TIA should be assessed within 24 hours and receives aspirin 300 mg daily unless contraindicated.
2Obtain urgent brain and carotid imaging according to the presentation, documenting side, degree and NASCET or ECST measurement convention.
3If 50–99% NASCET symptomatic stenosis is confirmed, refer urgently to the vascular team and aim for CEA within 14 days when the patient is suitable.
4Start or optimise antithrombotic treatment, lipid lowering, blood-pressure and diabetes care, smoking cessation and lifestyle support without waiting for surgery.
5Discuss procedural stroke, death, cranial nerve injury, myocardial infarction and haematoma against the substantial early natural-history risk.

02AlternativeBelow the surgical thresholdAlternativeThe relevant internal carotid stenosis is below 50% by NASCET criteria

1Do not offer CEA solely for this low-grade lesion because trial evidence does not show preventive benefit.
2Continue prompt best medical treatment because the patient has still had a vascular cerebral or retinal event.
3Investigate other causes, including atrial fibrillation, intracranial arterial disease, small-vessel disease and clinically relevant mimics.
4Reassess if symptoms recur or imaging quality was inadequate, rather than converting measurement conventions to manufacture a threshold.

03SafetyMajor or unstable strokeNeurology is worsening or imaging shows large infarction, haemorrhage or major brain injury

1Keep management within the hyperacute stroke unit and complete reperfusion, physiological and neurosurgical assessments as clinically indicated.
2Do not let an apparent carotid indication distract from airway, glucose, temperature, swallowing and intracranial complications.
3Ask the stroke neurologist and vascular surgeon to reassess candidacy and timing after neurological and radiological evolution is clear.
4Document why early intervention is deferred and set a dated plan for re-imaging or review so the decision is not lost.

Key medicines and prescribing safety3 treatments · regimens, roles and cautions

Provides immediate antiplatelet treatment while diagnosis, carotid imaging and definitive secondary prevention are arranged.

Aspirin

For suspected TIA, give 300 mg orally once daily immediately unless contraindicated; after acute ischaemic stroke, give 300 mg within 24 hours once haemorrhage is excluded and continue to 14 days or earlier discharge review.

Check active bleeding, aspirin hypersensitivity, previous severe aspirin dyspepsia, anticoagulants and planned reperfusion or surgery. Use a safe oral, enteral or rectal route after swallowing assessment; add a proton-pump inhibitor for previous aspirin-associated dyspepsia after checking interactions. After intravenous thrombolysis, withhold antiplatelets for the first 24 hours; reassess and obtain follow-up brain imaging excluding haemorrhage before initiation.

Reduces early recurrent non-cardioembolic events in selected minor stroke or TIA and supports longer-term antiplatelet prevention.

Clopidogrel

For the selected product, start within 24 hours of minor ischaemic stroke (NIHSS ≤3) or moderate-to-high-risk TIA (ABCD2 ≥4): clopidogrel 300 mg orally once as a loading dose, then 75 mg once daily with aspirin 75–100 mg once daily for 21 days, followed by single antiplatelet therapy. This eligibility criterion must not be used to delay any suspected-TIA referral; peri-CEA use follows the specialist carotid protocol.

Do not apply this product DAPT regimen to non-minor stroke, planned thrombolysis, anticoagulation or CEA without specialist direction. Contraindications include active pathological bleeding and severe hepatic impairment. Review bleeding, blood count symptoms, interacting anticoagulants or NSAIDs, and avoid routine omeprazole or esomeprazole because CYP2C19 inhibition can reduce activation.

High-intensity lipid lowering reduces recurrent vascular events as part of comprehensive secondary prevention after TIA or stroke.

Atorvastatin

For established cardiovascular disease, offer atorvastatin 80 mg orally once daily unless drug interactions, adverse-effect risk or patient preference indicate a lower dose; check response after 2–3 months.

Check baseline liver function, interactions, pregnancy status and prior muscle toxicity; use a lower starting dose when risk or interactions warrant it. Measure transaminases and lipids at 2–3 months, transaminases at 12 months, and creatine kinase only if unexplained muscle symptoms develop.

08ComplicationsImportant consequences, why they occur and why they matter clinically.

Recurrent ischaemic stroke

Further embolisation can cause disabling or fatal infarction, particularly in the first days after a symptomatic event when assessment or intervention is delayed.

Retinal infarction

Repeated ophthalmic emboli may progress from transient monocular visual loss to permanent retinal artery occlusion and lasting visual disability.

Procedural harm

CEA can cause perioperative stroke, myocardial infarction, cranial nerve injury, neck haematoma or death; benefit depends on keeping local complication rates acceptably low.

09Monitoring and follow-upTreatment response, safety checks and longer-term review.

Observe closely for recurrent TIA or stroke while awaiting intervention; any new deficit reactivates the emergency stroke pathway.
Record neurological status, functional independence and brain-imaging evolution because these determine whether early CEA remains safe.
Track the referral date, last-symptom date, imaging convention and planned procedure date to expose avoidable delay beyond 14 days.
Review bleeding, adherence and the intended stop or transition point for any short-course dual antiplatelet treatment.
Check blood pressure, smoking status, HbA1c when relevant and lipid response, aiming for LDL at most 2.0 mmol/L or non-HDL at most 2.6 mmol/L under NICE secondary prevention guidance.

10Special situationsVariants, exceptions and circumstances that change the usual approach.

Symptomatic means attributable

A recent ipsilateral event must fit the carotid territory. Finding plaque after dizziness, syncope or a contralateral event does not automatically make that plaque symptomatic.

The denominator matters

NASCET compares the narrowest residual lumen with the normal distal internal carotid artery. ECST uses the estimated original bulb, so percentages are not interchangeable.

Benefit is time sensitive

Most preventable recurrence occurs early. A theoretically suitable operation delayed for weeks loses benefit, which is why urgent imaging and parallel work-up matter.

Occlusion is different

A completely occluded internal carotid artery is not a very severe stenosis waiting for routine CEA. Confirm the distinction from near-occlusion and obtain specialist advice.

Mechanisms can coexist

Atrial fibrillation and carotid stenosis may coexist. Determine the most plausible stroke mechanism and preserve independent anticoagulation indications rather than treating one scan result in isolation.

11Common pitfallsFrequent interpretation and management errors.

01
Delaying a suspected TIA referral because an ABCD2 score appears low despite NICE advising assessment within 24 hours.
02
Calling a carotid lesion symptomatic without matching the side and retinal or hemispheric territory of the event.
03
Applying the 50% threshold to an unstated or ECST percentage and thereby choosing the wrong intervention pathway.
04
Sending a patient straight to elective carotid review while an ongoing deficit still needs hyperacute reperfusion assessment.
05
Assuming every high-grade lesion needs immediate surgery despite major disability, large infarction, haemorrhage or impaired consciousness.
06
Using carotid atherosclerosis alone as an indication for anticoagulation or failing to investigate atrial fibrillation.

Find your next topic